| Literature DB >> 24158143 |
Wen-Zhao Liu1, Ming-Jing He2, Long Long2, Dong-Liang Mu2, Ming-Shu Xu2, Xue Xing2, Xin Zeng2, Ga Liao2, Hong-Xia Dan2, Qian-Ming Chen2.
Abstract
Our previous salivary study had demonstrated an apparent T helper 2 (Th2)-predominance in saliva of oral lichen planus (OLP) patients and suggested a potential of salivary interleukin-4 (IL-4) as a biomarker for monitoring disease severity. To further determine the consistency of Th1/Th2 bias of OLP, this study investigated the expression profile of interferon-γ (IFN-γ) and IL-4 in serum and the relationship of the serum levels of these cytokines with their saliva partners. Sixty ethnic Chinese patients with OLP (40 of the erythematous/ulcerative form and 20 of the reticular form) were recruited for this study, with 40 age-sex-matched healthy volunteers as control group. IFN-γ and IL-4 levels in serum and paired saliva samples were screened by enzyme-linked immunosorbent assay. OLP patient showed a low-level IFN-γ but high-level IL-4 expression profile in both serum and saliva, with a lower IFN-γ/IL-4 ratio. Serum IL-4 level in the erythematous/ulcerative group was significantly higher than that in the reticular group. Serum levels of IFN-γ and IL-4 were significantly and positively correlated with their saliva partners. These results provided more evidence for Th2 cytokine-predominant immune imbalance in OLP, as well as the potential of IL-4 as the biomarker for monitoring severity of OLP.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24158143 PMCID: PMC3967304 DOI: 10.1038/ijos.2013.74
Source DB: PubMed Journal: Int J Oral Sci ISSN: 1674-2818 Impact factor: 6.344
Expression of IFN-γ and IL-4 in serum in OLP patients
| Items | IFN-γ /(ng⋅L−1) | IL-4 /(ng⋅L−1) | IFN-γ/IL-4 |
|---|---|---|---|
| OLP ( | 21.057±11.860* | 20.545±3.482* | 1.048±0.612* |
| Erythematous/ulcerative ( | 19.492±3.121*b | 21.188±3.511* | 0.925±0.606* |
| Reticular ( | 24.185±7.455* | 19.259±3.121 * | 1.296±0.472* |
| Control ( | 31.935±10.867 | 15.917±2.897 | 2.130±1.013 |
| OLP | |||
| Erythematous/ulcerative OLP | |||
| Reticular OLP | |||
| Erythematous/ulcerative OLP |
IFN, interferon; IL, interleukin; OLP, oral lichen planus.
*P<0.05 when compared with the control group.
Mean value of OLP group were calculated based on the erythematous/ulcerative group and reticular group.
Seven of the samples had a value below the assay detection range, and their values were estimated by the regression equation of standard curve.
Figure 1IFN- OLP, oral lichen planus; rOLP, reticular oral lichen planus; eOLP, erythematous/ulcerative oral lichen planus.
Figure 2IL-4 levels of serum saliva in OLP patients. IL, interferon; OLP, oral lichen planus; rOLP, reticular oral lichen planus; eOLP, erythematous/ulcerative OLP, oral lichen planus.
Expression of IFN-γ and IL-4 in saliva from OLP patients
| Items | IFN-γ /(ng⋅L−1) | IL-4 /(ng⋅L−1) | IFN-γ/IL-4 |
|---|---|---|---|
| OLP ( | 22.327±11.260* | 21.564±3.422* | 1.059±0.559* |
| Erythematous/ulcerative ( | 21.439±12.567*b | 22.317±3.779* | 0.983±0.606* |
| Reticular ( | 24.104±8.037* | 20.059±1.863 | 1.213±0.424* |
| Control ( | 33.517±14.968 | 19.624±1.221 | 1.728±0.821 |
| OLP | |||
| Erythematous/ulcerative OLP | |||
| Reticular OLP | |||
| Erythematous/ulcerative OLP |
IFN, interferon; IL, interleukin; OLP, oral lichen planus.
*P<0.05 when compared with the control group.
Mean value of OLP group were calculated based on the erythematous/ulcerative group and reticular group.
Two of the samples had a value below the assay detection range, and their values were estimated by the regression equation of standard curve.
Figure 3Correlations of cytokines levels between serum and saliva in OLP patients. OLP, oral lichen planus.